Hypophosphatemic Rickets with Hypercalciuria due to Mutation in SLC34A3/NaPi-IIc can be masked by Vitamin D Deficiency and can be Associated with Renal Calcifications

Abstract

Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is caused by mutations in SLC34A3, the gene encoding the renal sodium-phosphate co-transporter NaPi-IIc. Despite increased urinary calcium excretion, HHRH is typically not associated with kidney stones prior to treatment. However, here we describe two sisters, who displayed nephrolithiasis or nephrocalcinosis upon presentation. The index patient, II-4, presented with short stature, bone pain, and knee X-rays suggestive of mild rickets at age 8.5 years. Laboratory evaluation showed hypophosphatemia, elevated 1,25(OH)₂ vitamin D levels, and hypercalciuria, later also developing vitamin D deficiency. Her sister, II-6, had a low normal serum phosphorous level, biochemically vitamin D deficiency and no evidence for osteomalacia, but had undergone left nephro-ureterectomy at age 17 because of ureteral stricture secondary to renal calculi. Nucleotide sequence analysis of DNA from II-4 and II-6 revealed a homozygous missense mutation c.586G>A (p.G196R) in SLC34A3/NaPi-IIc. Ultrasonographic examinations prior to treatment showed grade I nephrocalcinosis for II-4, while II-6 had grade I-II nephrocalcinosis in her remaining kidney. Four siblings and the mother were heterozygous carriers of the mutation, but showed no biochemical abnormalities. With oral phosphate supplements, hypophosphatemia and hypercalciuria improved in both homozygous individuals. Renal calcifications that are presumably due to increased urinary calcium excretion can be the presenting finding in homozygous carriers of G196R in SLC34A3/NaPi-IIc, and some or all laboratory features of HHRH may be masked by vitamin D deficiency.

nephrocalcinosis - HHRH - Na-PiIIc

References

• 1 ADHR Consortium. . White KE, Evans WE, O’Riordan JLH, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Mettinger T, Strom TM. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.  Nat Genet. 2000;  26 345-348
• 2 Bacconi A, Virkki LV, Biber J, Murer H, Forster IC. Renouncing electroneutrality is not free of charge: switching on electrogenicity in a Na+-coupled phosphate cotransporter.  Proc Nat Acad Sci (USA). 2005;  102 ((35)) 12606-12611
• 3 Bacic D, Lehir M, Biber J, Kaissling B, Murer H, Wagner CA. The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.  Kidney Internl. 2006;  69 ((3)) 495-503
• 4 Ben-Ishay D, Dreyfuss F, Ullmann TD. Fanconi syndrome with hypouricemia in an adult: family study.  Am J Med. 1961;  31 793-800
• 5 Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabédian M, Sermet I, Fujiwara M, Morgan K, Tenenhouse HS, Jüppner H. SLC34A3 Mutations in patients with hereditary hypophosphataemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.  Am J Hum Genet. 2006;  78 ((2)) 179-192
• 6 Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.  J Clin Endocrinol Metab. 2005;  90 ((2)) 1012-1020
• 7 Chen C, Carpenter T, Steg N, Baron R, Anast C. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.  Pediatrics. 1989;  84 ((2)) 276-280
• 8 Drezner MK. Hypophosphatemic rickets.  Endocr Develop. 2003;  6 126-155
• 9 Drezner MK. Tumor-induced osteomalacia.  Rev Endocr Metab Disord. 2001;  2 ((2)) 175-186
• 10 Econs MJ, Drezner MK. Tumor-induced osteomalacia–unveiling a new hormone.  N Engl J Med. 1994;  330 ((23)) 1679-1681
• 11 Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.  Nat Genet. 2006;  38 ((11)) 1310-1315
• 12 Hoyer PF. In: Ultraschalldiagnostik in Pädiatrie und Kinderchirurgie. Lehrbuch und Atlas, Hofmann, V, Deeg, KH, Hoyer, PF, Thieme, 2. Edition New York 1996
• 13 HYP-Consortium . A gene (PHEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets.  Nat Genet. 1995;  11 130-136
• 14 Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, Econs MJ. Intronic deletions in the SLC34a3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.  J Clin Endocrinol Metab. 2006;  91 ((10)) 4022-4027
• 15 Kong A, Gudbjartson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. A high-resolution recombinant map of the human genome.  Nat Genet. 2002;  31 241-247
• 16 Leahey AM, Charnas LR, Nussbaum RL. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.  Hum Molec Genet. 1993;  2 ((4)) 461-463
• 17 Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV. A common molecular basis for three inherited kidney stone diseases.  Nature. 1996;  379 ((6564)) 445-449
• 18 Lorenz-Deperieux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Schnabel D, Hochberg Z, Strom TM. Hereditary hypophosphataemic rickets with hypercalciuria is caused by mutations in the sodium-phos-phate cotransporter gene SLC43A3.  Am J Hum Genet. 2006;  78 ((2)) 193-201
• 19 Miyamoto K, Segawa H, Ito M, Kuwahata M. Physiological regulation of renal sodium-dependent phosphate cotransporters.  Jpn J Physiol. 2004;  54 ((2)) 93-102
• 20 Nield LS, Majahan P, Joshi A, Kamat D. Rickets: Not a disease of the past.  Am Fam Phys. 2006;  74 619-626
• 21 Segawa H, Yamanaka S, Onitsuka A, Tomoe Y, Kuwahata M, Ito M, Taketani Y, Miyamoto K. Parathyroid hormone dependent endocytosis of renal type IIc Na/Pi cotransporter.  Am J Physiol Renal Physiol. 2007;  292 ((1)) F395-403 , . Epub 2006 Sep 19
• 22 Silberstein M, Tzemach A, Dovgolevsky N, Fishelson M, Schuster A, Geiger D. Online system for faster multipoint linkage analysis via parallel execution on thousands of personal computers.  Am J Hum Genet. 2006;  78 ((6)) 922-935
• 23 Tieder M, Blonder J, Strauss S, Shaked U, Maor J, Gabizon D, Manor H, Sela BA. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.  Nephron. 1993;  64 ((4)) 526-531
• 24 Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, Gabizon D, Liberman UA. Hereditary hypophosphatemic rickets with hypercalciuria.  N Engl J Med. 1985;  312 ((10)) 611-617
• 25 Weber G, Cazuffi MA, Frisone F, Angelis N de, Pasolini D, Tomaselli V, Chiumello G. Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol.  Child Nephrol Urol. 1988–1989;  ((5)) 9 273-276

1 BK and CB have contributed equally to this paper.

Correspondence